These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28060481)

  • 41. Single point mutation induced alterations in the equilibrium structural transitions on the folding landscape of HIV-1 protease.
    Rout MK; Reddy JG; Phillips M; Hosur RV
    J Biomol Struct Dyn; 2013; 31(7):684-93. PubMed ID: 22909351
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular dynamic and free energy studies of primary resistance mutations in HIV-1 protease-ritonavir complexes.
    Aruksakunwong O; Wolschann P; Hannongbua S; Sompornpisut P
    J Chem Inf Model; 2006; 46(5):2085-92. PubMed ID: 16995739
    [TBL] [Abstract][Full Text] [Related]  

  • 43. How inaccuracies in protein structure models affect estimates of protein-ligand interactions: computational analysis of HIV-I protease inhibitor binding.
    Thorsteinsdottir HB; Schwede T; Zoete V; Meuwly M
    Proteins; 2006 Nov; 65(2):407-23. PubMed ID: 16941468
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gated binding of ligands to HIV-1 protease: Brownian dynamics simulations in a coarse-grained model.
    Chang CE; Shen T; Trylska J; Tozzini V; McCammon JA
    Biophys J; 2006 Jun; 90(11):3880-5. PubMed ID: 16533835
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Understanding the basis of I50V-induced affinity decrease in HIV-1 protease via molecular dynamics simulations using polarized force field.
    Duan R; Lazim R; Zhang D
    J Comput Chem; 2015 Sep; 36(25):1885-92. PubMed ID: 26198456
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enthalpy-Entropy Compensation upon Molecular Conformational Changes.
    Ahmad M; Helms V; Lengauer T; Kalinina OV
    J Chem Theory Comput; 2015 Apr; 11(4):1410-8. PubMed ID: 26574352
    [TBL] [Abstract][Full Text] [Related]  

  • 47. De novo ligand design to an ensemble of protein structures.
    Todorov NP; Buenemann CL; Alberts IL
    Proteins; 2006 Jul; 64(1):43-59. PubMed ID: 16555306
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Restrained molecular dynamics simulations of HIV-1 protease: the first step in validating a new target for drug design.
    Perryman AL; Lin JH; McCammon JA
    Biopolymers; 2006 Jun; 82(3):272-84. PubMed ID: 16508951
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selected-fit versus induced-fit protein binding: kinetic differences and mutational analysis.
    Weikl TR; von Deuster C
    Proteins; 2009 Apr; 75(1):104-10. PubMed ID: 18798570
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Some insights into mechanism for binding and drug resistance of wild type and I50V V82A and I84V mutations in HIV-1 protease with GRL-98065 inhibitor from molecular dynamic simulations.
    Hu GD; Zhu T; Zhang SL; Wang D; Zhang QG
    Eur J Med Chem; 2010 Jan; 45(1):227-35. PubMed ID: 19910081
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HIV-1 protease molecular dynamics of a wild-type and of the V82F/I84V mutant: possible contributions to drug resistance and a potential new target site for drugs.
    Perryman AL; Lin JH; McCammon JA
    Protein Sci; 2004 Apr; 13(4):1108-23. PubMed ID: 15044738
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Determination of interaction kinetic constants for HIV-1 protease inhibitors using optical biosensor technology.
    Markgren PO; Lindgren MT; Gertow K; Karlsson R; Hämäläinen M; Danielson UH
    Anal Biochem; 2001 Apr; 291(2):207-18. PubMed ID: 11401294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular dynamics applied in drug discovery: the case of HIV-1 protease.
    Shang Y; Simmerling C
    Methods Mol Biol; 2012; 819():527-49. PubMed ID: 22183556
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations.
    Durdagi S; Mavromoustakos T; Chronakis N; Papadopoulos MG
    Bioorg Med Chem; 2008 Dec; 16(23):9957-74. PubMed ID: 18996019
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Flap Dynamics in Aspartic Proteases: A Computational Perspective.
    Mahanti M; Bhakat S; Nilsson UJ; Söderhjelm P
    Chem Biol Drug Des; 2016 Aug; 88(2):159-77. PubMed ID: 26872937
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Closing of the flaps of HIV-1 protease induced by substrate binding: a model of a flap closing mechanism in retroviral aspartic proteases.
    Tóth G; Borics A
    Biochemistry; 2006 May; 45(21):6606-14. PubMed ID: 16716071
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structural analysis of lead fullerene-based inhibitor bound to human immunodeficiency virus type 1 protease in solution from molecular dynamics simulations.
    Lee VS; Nimmanpipug P; Aruksakunwong O; Promsri S; Sompornpisut P; Hannongbua S
    J Mol Graph Model; 2007 Sep; 26(2):558-70. PubMed ID: 17468026
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Computational studies of darunavir into HIV-1 protease and DMPC bilayer: necessary conditions for effective binding and the role of the flaps.
    Leonis G; Czyżnikowska Ż; Megariotis G; Reis H; Papadopoulos MG
    J Chem Inf Model; 2012 Jun; 52(6):1542-58. PubMed ID: 22587384
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Accurate ensemble molecular dynamics binding free energy ranking of multidrug-resistant HIV-1 proteases.
    Sadiq SK; Wright DW; Kenway OA; Coveney PV
    J Chem Inf Model; 2010 May; 50(5):890-905. PubMed ID: 20384328
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative molecular dynamics study of dimeric and monomeric forms of HIV-1 protease in ligand bound and unbound state.
    Padariya M; Kalathiya U
    Gen Physiol Biophys; 2017 Apr; 36(2):141-154. PubMed ID: 27921997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.